We are happy to introduce a new series of interviews that highlights the real-world implementation of Foundation Models (FMs) and Large Language Models (LLMs). We start with an absolutely fascinating topic that can bring so many changes into our world: Bioengineering. In this insightful conversation with Barry Canton, CTO and co-founder of Ginkgo Bioworks, we discussed the evolution of synthetic biology, the integration of AI and GenAI in their R&D, and the future of bioengineering. Let's see what it takes to create a model that 'speaks DNA'.
Read further at https://www.turingpost.com/p/barrycanton-gingko
